Posterior ischemic optic neuropathy
ICD-10 H47.0 · ICD-11 9C40.41

Treatment of Posterior Ischemic Optic Neuropathy in Giant Cell Arteritis

Clinical Scenario

Arteritic posterior ischemic optic neuropathy (A-PION) arising from giant cell arteritis, in individuals aged 50 years or older. In this population, ruling out giant cell arteritis is the critical first step whenever posterior ischemic optic neuropathy is encountered.

Treatment Approach

Management of A-PION is similar to that of arteritic anterior ischemic optic neuropathy. High-dose systemic corticosteroid therapy must be started immediately, as an emergency measure. The complete regimen — including specific agents, dosing strategy, and the criteria for tapering — is set out in the full structured protocol.

Dosing details, monitoring parameters, and the full algorithmic guidance are available in the structured protocol below.

Treatment Goals
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.4103/0301-4738.77024

Arteritic PION (A-PION): due to GCA.

In all cases other than surgical PION, as in AION, the most important first step in persons aged 50 years or older is to rule out GCA always.

A-PION: Management is similar to that of A-AION discussed above.

high doses of systemic corticosteroid therapy must be started immediately, as an emergency measure.

High-dose steroid therapy must be maintained until both the ESR and CRP settle down to a stable, low level, which usually takes 2–3 weeks – CRP usually settles much earlier than the ESR.

View source ↗